Echo Therapeutics, Inc. 4/A
4/A · Echo Therapeutics, Inc. · Filed Mar 22, 2016
Insider Transaction Report
Form 4/AAmended
GOLDBERG MICHAEL M
Director
Transactions
- Award
Options (Right to Buy)
2016-03-21+150,000→ 18,750 totalExercise: $2.00Exp: 2026-03-21→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]On March 21, 2016, the compensation committee, with consent of holder, amended the terms of the option to increase the exercise price and extend the vesting period. As amended, 12.5% of the options vest immediately and 12.5% vest on each of April 1, 2016, July 1,2016, October 1, 2016, January 1, 2017, April 1, 2017, July 1, 2017, and October 1, 2017.
- [F2]Granted pursuant to the Echo Therapeutics, Inc. 2008 Equity Compensation Plan.